-
Signature
-
/s/ Patrick J. Christmas as attorney-in-fact
-
Issuer symbol
-
RGNX
-
Transactions as of
-
10 Mar 2026
-
Net transactions value
-
-$53,033
-
Form type
-
4
-
Filing time
-
12 Mar 2026, 18:17:39 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| PAKOLA STEVE |
Chief Medical Officer |
C/O REGENXBIO INC., 9804 MEDICAL CENTER DRIVE, ROCKVILLE |
/s/ Patrick J. Christmas as attorney-in-fact |
12 Mar 2026 |
0001700659 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RGNX |
Common Stock |
Sale |
$53,033 |
-5,124 |
-2% |
$10.35 |
247,926 |
10 Mar 2026 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: